Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor (Q39047793)

8 September 2017

Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor (English)

1 reference

8 September 2017

0 references

1 reference

1 reference

1

1 reference

8 September 2017

2

1 reference

8 September 2017

4

Klaus Pfizenmaier

1 reference

8 September 2017

Roland Kontermann

3

1 reference

PubMed ID

24310780

8 September 2017

Olaf Maier

series ordinal

5

1 reference

8 September 2017

6 December 2013

1 reference

8 September 2017

1 reference

8 September 2017

62

1 reference

8 September 2017

2

1 reference

8 September 2017

272-283

1 reference

Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Astrocytes promote myelination in response to electrical impulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Astrocytes in multiple sclerosis: a product of their environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Quantitative aspects of reactive gliosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Growth factor control of CNS myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Astrocytes--friends or foes in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Interleukin-1beta promotes repair of the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Role for CXCR2 and CXCL1 on glia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Workshop Summary: Introduction to Rational Design of New Means for Therapeutic Modulation of Function of the TNF Family

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Interleukin-6 expression in human multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22605

7 January 2021

Identifiers

DOI

10.1002/GLIA.22605

1 reference

8 September 2017

1 reference

PubMed ID

24310780